Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
- Conditions
- Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations
- Registration Number
- NCT02849977
- Lead Sponsor
- Rhythm Pharmaceuticals, Inc.
- Brief Summary
The purpose of this screening study is to identify people who have a rare genetic cause of obesity - specifically three genetic variants (a change in the DNA structure) of the POMC, PCSK1 and LepR genes that are currently known to result in obesity.
This screening study will not include any investigational drugs. You will be asked to provide a DNA sample and answer some questions about your medical history and hunger.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5966
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of individuals with POMC, LepR or PCSK1 genetic mutations 1 Year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (57)
Synexus Clinical Research US, Inc. - Simon Williamson Clinic, PC
πΊπΈBirmingham, Alabama, United States
Synexus Clinical Research US, Inc. - Phoenix Southeast
πΊπΈChandler, Arizona, United States
Clinical Research Advantage Inc.
πΊπΈMesa, Arizona, United States
Tucson Neuroscience Research - M3 Wake Research
πΊπΈTucson, Arizona, United States
PRI, LLC - Los Alamitos - M3 Wake Research
πΊπΈLos Alamitos, California, United States
Axis Clinical Trails
πΊπΈLos Angeles, California, United States
Axis Clinical Trials
πΊπΈLos Angeles, California, United States
PRI, LLC - Newport Beach - M3 Wake Research
πΊπΈNewport Beach, California, United States
Nemours Foundation Alfred Dupont Children's Hospital
πΊπΈWilmington, Delaware, United States
Children's National Medical Center
πΊπΈWashington, District of Columbia, United States
Scroll for more (47 remaining)Synexus Clinical Research US, Inc. - Simon Williamson Clinic, PCπΊπΈBirmingham, Alabama, United States